A 24 years old married female presented with
complaints of inability to conceive for last 3 years.
She gives history of irregular menstrual cycles (3-5
days/45-60 days), increased hair growth over the
face & breasts & acne for last 6 yrs. She also gives
history of weight gain of 8-10 kg over last 5-6 years.
Her coital history is normal and there is no history of
discharge from breasts or vagina. There is no history
suggestive of tuberculosis, thyroid disorder,
diabetes mellitus or hypertension. Her mother is
obese and diabetic. Her maternal aunt died of
uterine malignancy 2 years back.
On general physical examination:, Ht – 152cm; Wt –
68kg; Waist circumference – 38cm; Hip
circumference – 40cm; Waist / Hip circumference –
0.95; BMI – 29.43, Acne +; Hirsutism + with Ferriman
Gallway Score of 13; No acanthosis nigricans. BP –
130/90 mm of Hg ; Pulse- 86 per minute, regular. No
abnormality was detected on systemic and
gynaecological examination.
What is the probable diagnosis?
Polycystic ovarian syndrome (PCOS). It is the
commonest cause of anovulatory infertility with
acne, hirsutism and obesity. Family history of
diabetes and uterine malignancy is also pointing
towards a hereditary link of hyperoestrogenic
condition which is seen in this disease.
What are the criteria for diagnosing PCOS?
According to the revised 2003 diagnostic criteria of
PCOS [
1], the presence of any two out of the
following three suffices for the diagnosis of PCOS:
1. Oligo- or anovulation
2. Clinical and/or biochemical signs of
hyperandrogenism
3. Polycystic ovaries on ultrasound scan, defined
as the presence of 12 or more follicles in each ovary (with one ovary being sufficient for the
diagnosis), measuring 2-9 mm in diameter, and
or increased ovarian volume (>10mL), and/
exclusion of other etiologies.
What are the other causes of multiple ovarian
cysts on ultrasonography (USG)? How can
polycystic ovaries be differentiated from
multicystic ovaries?
Any condition which leads to chronic anovulation
can give rise to multiple small cysts in the ovary i.e.
congenital adrenal hyperplasia, virilizing tumors
and Cushing's syndrome. The typical findings on
sonogrpahy are described above and the increased
density of ovarian stroma differentiates polycystic
ovaries from multicystic ovaries. Multiple small
cysts in a single plane of the ovary on USG is
considered most characteristic of polycystic
ovaries, particularly if these cysts are peripherally
arranged in the so-called "pearl necklace"
configuration (Figure1).
What is the clinical presentation in PCOS?
The clinical spectrum of patients with PCOS varies
from mild hyperandrogenism with apparently
regular menses to more severe disorder with
manifestations of menstrualdisorders,
hyperandrogenism causing hirsutism, acne and
virilisation (rarely), anovulatory infertility, obesity
and other metabolic disorders at the other end of
the spectrum [
2]. These patients may present at any
time during reproductive age group and because of
varied symptoms, they may present to a
gynaecologist, reproductive endocrinologist,
physician, dermatologist or a dietician.
What is the pathophysiology of PCOS?
The basic pathology lies in dysregulation of enzyme
cytochrome P-450-17- α hydroxylase which is
present in ovaries and adrenals and has a genetic link. This enzyme system catalyses the activities of
two enzyme systems i.e. 17- hydroxylase and 17,
20 - lyase resulting in hyperandrogenism [
3,
4]. PCOS
is also associated with hyperinsulinemia and insulin
resistance [
2]. High insulin level probably acts at
multiple sites like ovary, liver, hypothalamopituitary
axis and the adrenal cortex. In the ovary
and adrenals it increases androgen production. In
liver it reduces the production of insulin growth
factor binding protein-1 (IGBF-1) and sex hormone
binding globulin (SHBG), which further increases
free androgen levels. High androgen levels prevent
development or maturation of follicles producing
polycystic ovaries, potentiates luteinizing hormone
(LH) and suppresses follicle stimulating hormone
(FSH). Under LH influence, cholesterol is converted
to androstenedione in the theca cell which is then
transferred to the granulosa cell to form oestrone
and oestradiol [
3]. Excess oestrogen increases
obesity and insulin resistance and thus a vicious
cycle is formed.
How will you work up a patient of PCOS?
Careful clinical history, physical examination and
laboratory investigations in these patients can
clinch the diagnosis.
Salient points on history [4]
• History of mode of onset and progress of
signs and symptoms.
• Age of onset and the pattern of past and
present menstruation- irregularity/oligomenorrhea /amenorrhea.
• Previous investigations and treatment
received and the results thereof.
• Personal history- occupation, life style,
history of low birth weight or precocious
puberty.
• Ethnic origin and family history of similar
problem and of diabetes mellitus.
Salient points on physical examination [4]
• Height, body weight, body mass index (BMI)
• Pulse rate, Blood pressure,
• Waist and hip circumference
• Signs of hyperandrogenism- hirsutism and
its distribution (Ferriman Galway score);
acne; pubic hair pattern; clitoral
enlargement.
• Hyperpigmentation, particularly on the
back and sides of the neck, axillae, skin
folds and pressor points.
• Breasts- lobule-alveolar development
which is less in case of chronic anovulation;
galactorrhoea
Laboratory investigations [4]
• Pelvic ultrasonography (transabdominal &
transvaginal), especially for polycystic
ovaries and stromal hypertrophy.
Endometrial hyperplasia should be
evaluated.
• Glucose tolerance test - measure glucose
and insulin at least at ‘0’ hour (fasting) and
at 2 hours after 75 g glucose given orally.
• Fasting levels of FSH, LH, prolactin, TSH,
testosterone, androstenedione, 17α OHprogesterone
& DHEAS, on any of day 3 to
5 after natural or progestin withdrawal
bleeding.
• Lipid profile
What are the treatment protocols for managing
infertility in PCOS?
ACOG (2002) recommends stepwise approach for
ovulation induction in PCOS
1. Weight loss by exercise and diet control: If BMI
2 >30 kg/m
2. Clomiphene citrate (CC) for ovulation
induction
3. CC + corticosteroids if DHEAS > 2 μg/ml
4. CC + Metformin (insulin sensitiser)
5. Low dose FSH injection
6. Low dose FSH injection + Metformin
7. Ovarian drilling
8. In Vitro Fertilisation
What are the long term implications of PCOS?
Young women with PCOS should be counselled
regarding the possible long-term risks associated
with this condition [5,6]. These are-
Definite: Type 2 diabetes (15%), Impaired glucose
tolerance (IGT) (18 - 20% ), Dyslipidemia
(Hypercholesterolemia with diminished HDL and
increased LDL), Endometrial cancer (OR 3.1, 95% CI
1.1 -7.3)
Possible: Hypertension, Cardiovascular disease,
Gestational diabetes mellitus, Pregnancy-induced
hypertension
Which are the two different distinct phenotypes of PCOS
patients?
There are two phenotypes of PCOS- Insulin
resistance (IR) Phenotype of PCOS- Associated with
abdominal obesity, Acanthosis Nigricans, hirsutism
and they are resistant to CC; and PCOS without IRThese
patients are lean, euinsulinemic/ euglycemic
and have enhanced ovarian sensitivity to insulin
(although no hyperinsulinemia exists).
Which tests can be used to determine insulin
resistance?
For the measurement of insulin resistance, the
following methods have been used [
4]:
a) The euglycemic insulin clamp
b) The minimal model
c) Fasting blood insulin level
d) Fasting glucose/insulin ratio
The first two are much more elaborate research
methods and not suitable for wider clinical use.
From a clinical perspective, the most practical way
and sensitive indicator of assessing insulin
resistance would seem to be the measurement of
insulin in plasma in the fasting state and/or after a
glucose load. In the majority of the patients, blood
level of fasting insulin is normal, but after glucose
load it shows exaggerated response.
References
- The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
- Guzick D. Polycystic ovary syndrome: symptomatology, pathophysiology and epidemiology. Am J Obstet Gynecol 1998;179: 89-93
- Shoham Z, Wwissman A. Polycystic ovarian disease: obesity and insulin resistance. In: RD Kempers (Eds). Fertility and Reproductive Medicine. 1998 Proc 16th World Congress on Fertility Sterility, San Francisco, Elsevier, Amsterdam, 263-72.
- R Somnath, Srivastav TG, Menon S, Basu A, Saxena P. An update on polycystic ovary syndrome- its investigation and management: Some researchable issues. Health and Population - Perspectives and Issues 2004:27:126-66.
- Mather KJ, Kwan F, Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 2000;73:150-56.
- Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c 17alpha activity and serum androgens. J Clin Endocrinol Metab 1997;82:4075-9.